Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How promising is neuroactive steroid drug discovery?
Carta MG, Paribello P, Preti A. Carta MG, et al. Among authors: paribello p. Expert Opin Drug Discov. 2018 Nov;13(11):993-995. doi: 10.1080/17460441.2018.1518974. Epub 2018 Sep 17. Expert Opin Drug Discov. 2018. PMID: 30221545 No abstract available.
Pharmacological management of depression in patients with multiple sclerosis.
Carta MG, Paribello P, Anastasia A, De Berardis D, Nardi AE, Fornaro M. Carta MG, et al. Among authors: paribello p. Expert Opin Pharmacother. 2018 Oct;19(14):1533-1540. doi: 10.1080/14656566.2018.1516207. Epub 2018 Sep 12. Expert Opin Pharmacother. 2018. PMID: 30207800 Review.
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder.
Pinna M, Manchia M, Pisanu C, Pinna F, Paribello P, Carta A, Meloni A, Conversano C, Del Zompo M, Mola F, Squassina A, Carpiniello B. Pinna M, et al. Among authors: paribello p. Psychiatr Genet. 2021 Oct 1;31(5):186-193. doi: 10.1097/YPG.0000000000000293. Psychiatr Genet. 2021. PMID: 34282075
Cost-Utility Analysis of Pharmacogenetic Testing Based on CYP2C19 or CYP2D6 in Major Depressive Disorder: Assessing the Drivers of Different Cost-Effectiveness Levels from an Italian Societal Perspective.
Carta A, Del Zompo M, Meloni A, Mola F, Paribello P, Pinna F, Pinna M, Pisanu C, Manchia M, Squassina A, Carpiniello B, Conversano C. Carta A, et al. Among authors: paribello p. Clin Drug Investig. 2022 Sep;42(9):733-746. doi: 10.1007/s40261-022-01182-2. Epub 2022 Aug 5. Clin Drug Investig. 2022. PMID: 35930170 Free PMC article.
40 results